The "street drug" Ecstasy may help suffers of post-traumatic stress learn to deal with their memories, according to an article in the Journal of Psychopharmacology.
Studies have shown that a type of psychological treatment called exposure therapy - where the patient repeatedly recalls the traumatic experience or is repeatedly exposed to situations that are safe, but still trigger their traumatic feelings - can be effective in relieving stress responses in patients with post-traumatic stress disorder and other anxious conditions. To improve outcomes, scientists have been investigating the use of drug therapies to enhance the effect of exposure therapy, making the result of exposure to the fear trigger easier, faster and more effective.
Psychiatrists that have administered 3,4-methylenedioxy-N-methylamphetamine, most commonly known by the street name ecstasy, to anxiety patients have noted that it promotes emotional engagement; strengthens the bond between the patient and doctor, known as the therapeutic alliance; decreases emotional avoidance; and improves tolerance for recall and processing of painful memories.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze